Abstract

Objectives: Multiple options with similar cure rates exist for men with localized adenocarcinoma of the prostate. Therefore, treatment-related morbidity is a major consideration for treatment selection. We present a descriptive, longitudinal analysis of genitourinary and bowel symptoms following treatment in a brachytherapy registry at the University of Cincinnati. Methods: Between 1995 and 2007, 394 consecutive patients with newly diagnosed early stage prostate cancer underwent radioactive 125I...